Sophie Laurent

Q: What Schools Are Affiliated With Sophie Laurent

Sophie Laurent is affiliated with the following schools: Wuhan University, Université Paris Cité, University of Mons-Hainaut, University of Mons, Stanford University, Aix-Marseille University

Sophie Laurent's AcademicInfluence.com Rankings

Sophie Laurent

Computer Science

#5368

World Rank

#5673

Historical Rank

Machine Learning

#1395

World Rank

#1417

Historical Rank

Artificial Intelligence

#1628

World Rank

#1659

Historical Rank

Database

#2520

World Rank

#2641

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Sophie Laurent's Degrees

PhD Computer Science Université Paris Cité
Bachelors Computer Science Université Paris Cité

Similar Degrees You Can Earn

Why Is Sophie Laurent Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Sophie Laurent's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. (2008) (5748)
Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. (2011) (1529)
Protein-nanoparticle interactions: opportunities and challenges. (2011) (1145)
Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles. (2011) (1128)
Toxicity of nanomaterials. (2012) (827)
Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for in vivo imaging. (2007) (691)
Graphene: promises, facts, opportunities, and challenges in nanomedicine. (2013) (603)
Protein-Nanoparticle Interactions (2013) (496)
Classification and basic properties of contrast agents for magnetic resonance imaging. (2009) (484)
Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents. (2006) (384)
Magnetic resonance imaging tracking of stem cells in vivo using iron oxide nanoparticles as a tool for the advancement of clinical regenerative medicine. (2011) (377)
Nanoadsorbents: classification, preparation, and applications (with emphasis on aqueous media). (2013) (375)
Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges (2014) (349)
Toxicity evaluations of superparamagnetic iron oxide nanoparticles: cell "vision" versus physicochemical properties of nanoparticles. (2011) (322)
Effect of nanoparticles on the cell life cycle. (2011) (302)
Heterocyst differentiation and pattern formation in cyanobacteria: a chorus of signals (2006) (272)
Magnetic iron oxide nanoparticles for drug delivery: applications and characteristics (2018) (254)
Engineered nanoparticles for biomolecular imaging. (2011) (243)
A High‐Performance Magnetic Resonance Imaging T2 Contrast Agent (2007) (228)
Personalized protein coronas: a "key" factor at the nanobiointerface. (2014) (199)
Dual anticancer drug/superparamagnetic iron oxide-loaded PLGA-based nanoparticles for cancer therapy and magnetic resonance imaging. (2013) (192)
Stability of MRI Paramagnetic Contrast Media: A Proton Relaxometric Protocol for Transmetallation Assessment (2001) (191)
Irreversible changes in protein conformation due to interaction with superparamagnetic iron oxide nanoparticles. (2011) (189)
Efficient internalization of silica-coated iron oxide nanoparticles of different sizes by primary human macrophages and dendritic cells. (2011) (176)
Therapeutic benefits from nanoparticles: the potential significance of nanoscience in diseases with compromise to the blood brain barrier. (2013) (173)
Crucial Ignored Parameters on Nanotoxicology: The Importance of Toxicity Assay Modifications and “Cell Vision” (2012) (171)
Magnetic iron oxide nanoparticles for biomedical applications. (2010) (162)
Ultrasmall rigid particles as multimodal probes for medical applications. (2011) (158)
Personalized disease-specific protein corona influences the therapeutic impact of graphene oxide. (2015) (153)
Cell "vision": complementary factor of protein corona in nanotoxicology. (2012) (147)
Magnetic targeting of surface-modified superparamagnetic iron oxide nanoparticles yields antibacterial efficacy against biofilms of gentamicin-resistant staphylococci. (2012) (146)
Injectable Superparamagnetic Ferrogels for Controlled Release of Hydrophobic Drugs (2009) (145)
Big signals from small particles: regulation of cell signaling pathways by nanoparticles. (2013) (145)
Nonmetabolizable analogue of 2-oxoglutarate elicits heterocyst differentiation under repressive conditions in Anabaena sp. PCC 7120. (2005) (137)
Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of multiple sclerosis. (2011) (135)
Synthesis, Functionalization, and Design of Magnetic Nanoparticles for Theranostic Applications (2017) (134)
Protein fibrillation and nanoparticle interactions: opportunities and challenges. (2013) (133)
Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of cancer. (2011) (132)
Spin transition molecular materials: intelligent contrast agents for magnetic resonance imaging. (2003) (131)
Hydrogels incorporating GdDOTA: towards highly efficient dual T1/T2 MRI contrast agents. (2012) (127)
Macromolecular Ligands for Gadolinium MRI Contrast Agents (2012) (126)
Nanoparticle and Protein Corona (2013) (120)
Contrast agents: magnetic resonance. (2008) (115)
Specific E-selectin targeting with a superparamagnetic MRI contrast agent. (2006) (112)
MRI detection of early endothelial activation in brain inflammation (2004) (109)
Uniform mesoporous silica coated iron oxide nanoparticles as a highly efficient, nontoxic MRI T(2) contrast agent with tunable proton relaxivities. (2012) (108)
High quality and tuneable silica shell–magnetic core nanoparticles (2010) (107)
A multinuclear MR study of Gd‐EOB‐DTPA: Comprehensive preclinical characterization of an organ specific MRI contrast agent (1997) (106)
Superparamagnetic iron oxide nanoparticles for in vivo molecular and cellular imaging. (2015) (103)
Mastering the Shape and Composition of Dendronized Iron Oxide Nanoparticles To Tailor Magnetic Resonance Imaging and Hyperthermia (2014) (100)
Molecular imaging of alpha v beta3 integrin expression in atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA. (2008) (96)
Physicochemical Characterization of MS‐325, a New Gadolinium Complex, by Multinuclear Relaxometry (1999) (92)
Magnetoliposomes as multimodal contrast agents for molecular imaging and cancer nanotheragnostics. (2011) (91)
Protein corona affects the relaxivity and MRI contrast efficiency of magnetic nanoparticles. (2013) (91)
Iron oxide based MR contrast agents: from chemistry to cell labeling. (2009) (89)
MR molecular imaging of early endothelial activation in focal ischemia (2004) (86)
Development of a Magnetic Resonance Imaging Protocol for the Characterization of Atherosclerotic Plaque by Using Vascular Cell Adhesion Molecule-1 and Apoptosis-Targeted Ultrasmall Superparamagnetic Iron Oxide Derivatives (2012) (86)
How to quantify iron in an aqueous or biological matrix: a technical note. (2009) (83)
Superparamagnetic nanosystems based on iron oxide nanoparticles for biomedical imaging. (2011) (82)
Dy‐DTPA derivatives as relaxation agents for very high field MRI: The beneficial effect of slow water exchange on the transverse relaxivities (2002) (81)
How to measure the transmetallation of a gadolinium complex. (2010) (80)
Dietary enrichment of edible insects with omega 3 fatty acids (2019) (80)
Peptidic targeting of phosphatidylserine for the MRI detection of apoptosis in atherosclerotic plaques. (2009) (79)
Significance of cell "observer" and protein source in nanobiosciences. (2013) (74)
Hard corona composition and cellular toxicities of the graphene sheets. (2013) (72)
Polyglycerol-grafted superparamagnetic iron oxide nanoparticles: highly efficient MRI contrast agent for liver and kidney imaging and potential scaffold for cellular and molecular imaging. (2012) (71)
Relaxometric Studies of γ-Fe2O3@SiO2 core shell nanoparticles: when the coating matters (2012) (66)
Potential MRI contrast agents based on micellar incorporation of amphiphilic bis(alkylamide) derivatives of [(Gd-DTPA)(H2O)](2-) (2003) (65)
Heat-triggered drug release systems based on mesoporous silica nanoparticles filled with a maghemite core and phase-change molecules as gatekeepers. (2014) (65)
Gadolinium DTPA-Monoamide Complexes Incorporated into Mixed Micelles as Possible MRI Contrast Agents (2004) (64)
Gold nanomaterials as key suppliers in biological and chemical sensing, catalysis, and medicine. (2019) (64)
In Vivo Detection of Inflammation Using Pegylated Iron Oxide Particles Targeted at E-Selectin: A Multimodal Approach Using MR Imaging and EPR Spectroscopy (2009) (64)
High Relaxivities and Strong Vascular Signal Enhancement for NaGdF4 Nanoparticles Designed for Dual MR/Optical Imaging (2013) (64)
Nanotoxicology: advances and pitfalls in research methodology. (2015) (64)
Proteomics Analysis Reveals Distinct Corona Composition on Magnetic Nanoparticles with Different Surface Coatings: Implications for Interactions with Primary Human Macrophages (2015) (63)
Magnetic resonance imaging of inflammation with a specific selectin‐targeted contrast agent (2005) (62)
Iron oxide–gold core–shell nano-theranostic for magnetically targeted photothermal therapy under magnetic resonance imaging guidance (2019) (61)
Regulation of stem cell fate by nanomaterial substrates. (2015) (57)
C-MALISA (cellular magnetic-linked immunosorbent assay), a new application of cellular ELISA for MRI. (2005) (56)
An increase in the level of 2-oxoglutarate promotes heterocyst development in the cyanobacterium Anabaena sp. strain PCC 7120. (2003) (56)
Optimization of the Synthesis of Superparamagnetic Contrast Agents by the Design of Experiments Method (2008) (55)
Functionalization of small rigid platforms with cyclic RGD peptides for targeting tumors overexpressing αvβ3-integrins. (2013) (54)
Bimodal system (luminophore and paramagnetic contrastophore) derived from Ln(III) complexes based on a bipyridine-containing macrocyclic ligand. (2005) (53)
The receiver domain of FrzE, a CheA–CheY fusion protein, regulates the CheA histidine kinase activity and downstream signalling to the A‐ and S‐motility systems of Myxococcus xanthus (2008) (53)
Protein-Nanoparticle Interactions: The Bio-Nano Interface (2013) (53)
Synthesis and processing of magnetic nanoparticles (2015) (52)
Synthesis and in vitro evaluation of MR molecular imaging probes using J591 mAb-conjugated SPIONs for specific detection of prostate cancer. (2013) (52)
Simulation-guided photothermal therapy using MRI-traceable iron oxide-gold nanoparticle. (2019) (51)
Magnetic labeling of non-phagocytic adherent cells with iron oxide nanoparticles: a comprehensive study. (2008) (50)
Glucose-, pH- and thermo-responsive nanogels crosslinked by functional superparamagnetic maghemite nanoparticles as innovative drug delivery systems. (2014) (49)
Synthesis and Characterization of Various Benzyl Diethylenetriaminepentaacetic Acids (dtpa) and Their Paramagnetic Complexes, Potential Contrast Agents for Magnetic Resonance Imaging (2000) (48)
Interdisciplinary challenges and promising theranostic effects of nanoscience in Alzheimer's disease (2012) (48)
A New Peptidic Vector for Molecular Imaging of Apoptosis, Identified by Phage Display Technology (2006) (47)
Magnetic resonance molecular imaging of vascular cell adhesion molecule-1 expression in inflammatory lesions using a peptide-vectorized paramagnetic imaging probe. (2009) (47)
Can the theoretical fitting of the proton-nuclear-magnetic-relaxation-dispersion (proton NMRD) curves of paramagnetic complexes be improved by independent measurement of their self-diffusion coefficients? (2005) (47)
Nanoparticles Based on Star Polymers as Theranostic Vectors: Endosomal‐Triggered Drug Release Combined with MRI Sensitivity (2015) (47)
Potential amyloid plaque-specific peptides for the diagnosis of Alzheimer's disease (2010) (46)
A new approach to follow the formation of iron oxide nanoparticles synthesized by thermal decomposition (2013) (46)
A heterobimetallic ruthenium-gadolinium complex as a potential agent for bimodal imaging. (2011) (46)
Manganese-impregnated mesoporous silica nanoparticles for signal enhancement in MRI cell labelling studies. (2013) (45)
C10-modified artemisinin derivatives: efficient heme-alkylating agents. (2005) (44)
Synthesis, characterization, and pharmacokinetic evaluation of a potential MRI contrast agent containing two paramagnetic centers with albumin binding affinity. (2005) (43)
Corona protein composition and cytotoxicity evaluation of ultra-small zeolites synthesized from template free precursor suspensions (2013) (43)
Synthesis and physicochemical characterization of Gd-DTPA-B(sLex)A, a new MRI contrast agent targeted to inflammation. (2004) (43)
Synthesis and Physicochemical Characterisation of Gd‐DTPA Derivatives as Contrast Agents for MRI (2012) (43)
Synthesis of "Trioxaquantel" ® Derivatives as Potential New Antischistosomal Drugs (2008) (43)
Comprehensive investigation of the non-covalent binding of MRI contrast agents with human serum albumin (2007) (43)
In vitro biomedical applications of functionalized iron oxide nanoparticles, including those not related to magnetic properties. (2010) (43)
Hyperthermia-induced protein corona improves the therapeutic effects of zinc ferrite spinel-graphene sheets against cancer (2014) (42)
Metal Chelating Crosslinkers Form Nanogels with High Chelation Stability. (2013) (42)
Gold nanoparticle-mediated bubbles in cancer nanotechnology. (2020) (41)
Fabrication of Nanofibrous PVA/Alginate-Sulfate Substrates for Growth Factor Delivery. (2018) (41)
Relating the Surface Properties of Superparamagnetic Iron Oxide Nanoparticles (SPIONs) to Their Bactericidal Effect towards a Biofilm of Streptococcus mutans (2016) (40)
The Precise Molecular Location of Gadolinium Atoms has a Significant Influence on the Efficacy of Nanoparticulate MRI Positive Contrast Agents (2014) (40)
Carboxy-silane coated iron oxide nanoparticles: a convenient platform for cellular and small animal imaging. (2014) (40)
Pharmacokinetic and in vivo evaluation of a self-assembled gadolinium(III)-iron(II) contrast agent with high relaxivity. (2006) (39)
Tetranuclear d-f metallostars: synthesis, relaxometric, and luminescent properties. (2012) (39)
Superparamagnetic Iron Oxide Nanoparticles (2017) (39)
Nano-thermometers with thermo-sensitive polymer grafted USPIOs behaving as positive contrast agents in low-field MRI. (2015) (39)
How to perform accurate and reliable measurements of longitudinal and transverse relaxation times of MRI contrast media in aqueous solutions. (2009) (38)
A self-assembled complex with a titanium(IV) catecholate core as a potential bimodal contrast agent. (2012) (38)
A tripodal ruthenium-gadolinium metallostar as a potential α(v)β(3) integrin specific bimodal imaging contrast agent. (2012) (37)
Hepatic and Renal Toxicity Induced by TiO2 Nanoparticles in Rats: A Morphological and Metabonomic Study (2019) (37)
Calix[4]arenes as molecular platforms for magnetic resonance imaging (MRI) contrast agents. (2009) (36)
Stereospecific binding of MRI contrast agents to human serum albumin: the case of Gd-(S)-EOB-DTPA (Eovist) and its (R) isomer (2001) (36)
In vitro characterization of the Gd complex of [2,6-pyridinediylbis(methylene nitrilo)] tetraacetic acid (PMN-tetraacetic acid) and of its Eu analogue, suitable bimodal contrast agents for MRI and optical imaging. (2007) (36)
A dual lanthanide probe suitable for optical (Tb3+ luminescence) and magnetic resonance imaging (Gd3+ relaxometry). (2006) (35)
Mechanistic Insight into Heptosyltransferase Inhibition by using Kdo Multivalent Glycoclusters. (2016) (35)
Iminoethenethiones, Rn=c=c=s - Characterization by Neutralization-Reionization Mass-Spectrometry and G2(Mp2) Theory (1994) (35)
New mono-ether of glycerol and triterpenes with DPPH radical scavenging activity from Cameroonian propolis (2017) (35)
Polymer–gold nanohybrids with potential use in bimodal MRI/CT: enhancing the relaxometric properties of Gd(III) complexes (2012) (34)
Size-controlled synthesis of CoFe 2 O 4 nanoparticles potential contrast agent for MRI and investigation on their size-dependent magnetic properties (2013) (34)
Synthesis, variable temperature and pressure 17O NMR study of bis(alkylamide) derivatives of [(Gd-DTPA)(H2O)]2- - An assessment of the substitution effect on water exchange kinetics (2002) (33)
Superparamagnetic iron oxide nanoparticles alter expression of obesity and T2D-associated risk genes in human adipocytes (2013) (33)
Poly(acrylic acid)-block-poly(vinyl alcohol) anchored maghemite nanoparticles designed for multi-stimuli triggered drug release. (2013) (32)
Dual nano-sized contrast agents in PET/MRI: a systematic review. (2016) (31)
Infection-resistant MRI-visible scaffolds for tissue engineering applications (2016) (31)
Morphological alterations induced by the exposure to TiO2 nanoparticles in primary cortical neuron cultures and in the brain of rats (2018) (31)
Relaxivities of paramagnetic liposomes: on the importance of the chain type and the length of the amphiphilic complex (2008) (31)
An original route to stabilize and functionalize magnetite nanoparticles for theranosis applications (2011) (31)
Validation of a dendron concept to tune colloidal stability, MRI relaxivity and bioelimination of functional nanoparticles. (2015) (31)
Relaxometric study of copper [15]metallacrown-5 gadolinium complexes derived from alpha-aminohydroxamic acids. (2005) (30)
Paramagnetic liposomes: inner versus outer membrane relaxivity of DPPC liposomes incorporating lipophilic gadolinium complexes. (2008) (30)
Phage Display Screening for Tumor Necrosis Factor-α-Binding Peptides: Detection of Inflammation in a Mouse Model of Hepatitis (2013) (30)
Biocompatible and fluorescent superparamagnetic iron oxide nanoparticles with superior magnetic properties coated with charged polysaccharide derivatives. (2017) (30)
Functionalized Magnetic Nanoparticles for the Detection and Quantitative Analysis of Cell Surface Antigen (2012) (30)
Iron oxide particles covered with hexapeptides targeted at phosphatidylserine as MR biomarkers of tumor cell death. (2010) (30)
MRI-based numerical modeling strategy for simulation and treatment planning of nanoparticle-assisted photothermal therapy. (2019) (29)
Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library (2011) (29)
Synthesis of a new gadolinium complex with a high affinity for human serum albumin and its manifold physicochemical characterization by proton relaxation rate analysis, NMR diffusometry and electrospray mass spectrometry. (2008) (29)
Paramagnetic liposomes containing amphiphilic bisamide derivatives of Gd-DTPA with aromatic side chain groups as possible contrast agents for magnetic resonance imaging (2005) (29)
Mn(II)-containing coordination nanoparticles as highly efficient T(1) contrast agents for magnetic resonance imaging. (2014) (29)
Superparamagnetic Iron Oxide Nanoparticles for MRI (2013) (28)
Tuning the composition of biocompatible Gd nanohydrogels to achieve hypersensitive dual T1/T2 MRI contrast agents. (2014) (28)
Studying the signaling role of 2-oxoglutaric acid using analogs that mimic the ketone and ketal forms of 2-oxoglutaric acid. (2006) (28)
A new metallostar complex based on an aluminum(III) 8-hydroxyquinoline core as a potential bimodal contrast agent. (2012) (27)
Synthesis of a Sialyl LewisX Mimetic Conjugated with DTPA, Potential Ligand of New Contrast Agents for Medical Imaging (2002) (27)
Cell‐type specific modification of PII is involved in the regulation of nitrogen metabolism in the cyanobacterium Anabaena PCC 7120 (2004) (27)
Development of magnetic chromatography to sort polydisperse nanoparticles in ferrofluids. (2010) (27)
Antioxidant, antibacterial and cell toxicity effects of polyphenols from Ahmeur Bouamer grape seed extracts (2017) (27)
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications (2008) (27)
Micellar self-assemblies of gadolinium(III)/europium(III) amphiphilic complexes as model contrast agents for bimodal imaging. (2014) (27)
Lanthanide(III) Complexes of Diethylenetriaminepentaacetic Acid (DTPA)–Bisamide Derivatives as Potential Agents for Bimodal (Optical/Magnetic Resonance) Imaging (2013) (27)
Combinatorial effects of radiofrequency hyperthermia and radiotherapy in the presence of magneto‐plasmonic nanoparticles on MCF‐7 breast cancer cells (2019) (26)
Liposomes with conjugates of a calix[4]arene and a Gd-DOTA derivative on the outside surface; an efficient potential contrast agent for MRI. (2010) (25)
Influence of the length of the coating molecules on the nuclear magnetic relaxivity of superparamagnetic colloids (2004) (25)
Galectin-1 is a diagnostic marker involved in thyroid cancer progression (2017) (25)
Inactivation of spkD, encoding a Ser/Thr kinase, affects the pool of the TCA cycle metabolites in Synechocystis sp. strain PCC 6803. (2008) (25)
An Assessment of the Potential Relationship between the Charge of Gd–DTPA Complexes and the Exchange Rate of the Water Coordinated to the Metal (2008) (24)
MRI Contrast Agents (2017) (24)
New carboxysilane-coated iron oxide nanoparticles for nonspecific cell labelling. (2013) (24)
Multinuclear magnetic resonance characterization of paramagnetic contrast agents. The manifold effects of concentration and counterions. (1998) (24)
A comparative physicochemical, morphological and magnetic study of silane-functionalized superparamagnetic iron oxide nanoparticles prepared by alkaline coprecipitation. (2016) (24)
Magnetic fl uid hyperthermia : Focus on superparamagnetic iron oxide nanoparticles (2011) (24)
Bis(phenylethylamide) Derivatives of Gd-DTPA as Potential Receptor-Specific MRI Contrast Agents (2007) (23)
Dysprosium complexes and their micelles as potential bimodal agents for magnetic resonance and optical imaging. (2013) (23)
Controlled synthesis of a novel heteropolymetallic complex with selectively incorporated lanthanide(III) ions. (2014) (23)
Dy-complexes as high field T2 contrast agents: influence of water exchange rates. (2002) (23)
In vitro and in vivo characterization of several functionalized ultrasmall particles of iron oxide, vectorized against amyloid plaques and potentially able to cross the blood-brain barrier: toward earlier diagnosis of Alzheimer's disease by molecular imaging. (2015) (23)
Lanthanide complexes for magnetic resonance and optical molecular imaging. (2009) (23)
PEGylated superparamagnetic iron oxide nanoparticles labeled with 68Ga as a PET/MRI contrast agent: a biodistribution study (2016) (23)
Effect of chain length and electrical charge on properties of ammonium-bearing bisphosphonate-coated superparamagnetic iron oxide nanoparticles: formulation and physicochemical studies (2010) (22)
Iron oxide nanosized clusters embedded in porous nanorods: a new colloidal design to enhance capabilities of MRI contrast agents. (2010) (22)
Synthesis and physicochemical characterization of new squalenoyl amphiphilic gadolinium complexes as nanoparticle contrast agents. (2011) (22)
VCAM-1 Target in Non-Invasive Imaging for the Detection of Atherosclerotic Plaques (2020) (22)
Metal Oxide Particles and Their Prospects for Applications (2018) (22)
Fluorescent magnetic nanoparticles for cell labeling: flux synthesis of manganite particles and novel functionalization of silica shell. (2015) (21)
High-relaxivity and luminescent silica nanoparticles as multimodal agents for molecular imaging. (2013) (21)
Relaxivity and Transmetallation Stability of New Benzyl-Substituted Derivatives of GadoliniumDTPA Complexes (2004) (21)
Development of a peptide-functionalized imaging nanoprobe for the targeting of (FXYD2)γa as a highly specific biomarker of pancreatic beta cells. (2015) (21)
Human alveolar epithelial cell responses to core-shell superparamagnetic iron oxide nanoparticles (SPIONs). (2015) (20)
Control of the synthesis of magnetic fluids by relaxometry and magnetometry (2004) (20)
Photoacoustic temperature imaging based on multi-wavelength excitation (2018) (20)
IMINOETHENONE RADICAL CATIONS (RN=C=C=O-CENTER-DOT+) - TANDEM MASS-SPECTROMETRY AND AB-INITIO MO STUDIES (1994) (20)
Investigation of non-covalent interactions between paramagnetic complexes and human serum albumin by electrospray mass spectrometry. (2004) (20)
Selective liquid phase oxidation of ethyl benzene to acetophenone by palladium nanoparticles immobilized on a g-C3N4–rGO composite as a recyclable catalyst (2019) (20)
Molecular Imaging: From Bench to Clinic (2014) (20)
N (1)-Fluoroalkyltryptophan Analogues: Synthesis and in vitro Study as Potential Substrates for Indoleamine 2,3-Dioxygenase. (2015) (19)
Structure, synthesis and characterization of contrast agents for magnetic resonance molecular imaging (2007) (19)
Synthesis and Characterization of PEGylated and Fluorinated Chitosans: Application to the Synthesis of Targeted Nanoparticles for Drug Delivery. (2017) (19)
From phage display to magnetophage, a new tool for magnetic resonance molecular imaging. (2007) (18)
Multimodal assessment of early tumor response to chemotherapy: comparison between diffusion‐weighted MRI, 1H‐MR spectroscopy of choline and USPIO particles targeted at cell death (2012) (18)
Optimising the design of paramagnetic MRI contrast agents: influence of backbone substitution on the water exchange rate of Gd-DTPA derivatives (2004) (18)
Importance of DOTA derivatives in bimodal imaging (2017) (18)
Terpyridine-based heteroditopic ligand for Ru(II)Ln3(III) metallostar architectures (Ln = Gd, Eu, Nd, Yb) with MRI/optical or dual-optical responses. (2015) (17)
Heme alkylation by artemisinin and trioxaquines (2006) (17)
Ultrasmall particle of iron oxide--RGD peptidomimetic conjugate: synthesis and characterisation. (2010) (17)
Discrimination of Regioisomeric and Stereoisomeric Saponins from Aesculus hippocastanum Seeds by Ion Mobility Mass Spectrometry (2019) (17)
Silencing of casein kinase 1 delta reduces migration and metastasis of triple negative breast cancer cells (2018) (17)
Fluorophore-tagged superparamagnetic iron oxide nanoparticles as bimodal contrast agents for MR/optical imaging (2016) (17)
Charge effect of superparamagnetic iron oxide nanoparticles on their surface functionalization by photo-initiated chemical vapour deposition (2015) (17)
Magnetofluorescent micellar complexes of terbium(III) as potential bimodal contrast agents for magnetic resonance and optical imaging. (2015) (16)
Study of non-covalent interactions between MRI contrast agents and human serum albumin by NMR diffusometry (2009) (16)
Lipids constituents from Gardenia aqualla Stapf & Hutch (2018) (16)
Control of Biological Hazards in Insect Processing: Application of HACCP Method for Yellow Mealworm (Tenebrio molitor) Powders (2020) (16)
Ultrasmall Superparamagnetic Iron Oxide Nanoparticles with Europium(III) DO3A as a Bimodal Imaging Probe. (2016) (16)
Silica Coated Iron/Iron Oxide Nanoparticles as a Nano-Platform for T2 Weighted Magnetic Resonance Imaging (2019) (16)
Metallic bismuth nanoparticles: Towards a robust, productive and ultrasound assisted synthesis from batch to flow-continuous chemistry. (2019) (16)
VSION as high field MRI T1 contrast agent: evidence of their potential as positive contrast agent for magnetic resonance angiography (2018) (15)
Related physicochemical, rheological, and dielectric properties of nanocomposites of superparamagnetic iron oxide nanoparticles with polyethyleneglycol (2020) (15)
Influence of Experimental Parameters of a Continuous Flow Process on the Properties of Very Small Iron Oxide Nanoparticles (VSION) Designed for T1-Weighted Magnetic Resonance Imaging (MRI) (2020) (15)
New Bifunctional Contrast Agents: Bis-Amide Derivatives of C-Substituted Gd-DTPA (2004) (15)
HR-MAS NMR spectroscopy: an innovative tool for the characterization of iron oxide nanoparticles tracers for molecular imaging. (2015) (15)
A new magnetic resonance imaging contrast agent loaded into poly(lacide-co-glycolide) nanoparticles for long-term detection of tumors (2014) (15)
Biocompatible nanoparticles and gadolinium complexes for MRI applications (2013) (15)
Raman active jagged-shaped gold-coated magnetic particles as a novel multimodal nanoprobe. (2011) (15)
Structure and Dynamics of Lanthanide Complexes of Triethylenetetramine-N,N,N',N'',N''',N'''-hexaacetic Acid (H6ttha) and of Diamides H4ttha(NHR) Derived from H6ttha as Studied by NMR, NMRD, and EPR (2005) (15)
Influence of experimental parameters on iron oxide nanoparticle properties synthesized by thermal decomposition: size and nuclear magnetic resonance studies (2018) (15)
Characterization of iminopropadienone ions and neutrals in a tandem mass spectrometer (1992) (14)
Toxicity of TiO2 nanoparticles on the NRK52E renal cell line (2017) (14)
Modulation of Relaxivity, Suspension Stability, and Biodistribution of Dendronized Iron Oxide Nanoparticles as a Function of the Organic Shell Design (2015) (14)
Minor changes in the macrocyclic ligands but major consequences on the efficiency of gold nanoparticles designed for radiosensitization. (2016) (14)
Development of New Glucosylated Derivatives of Gadolinium Diethylenetriaminepentaacetic for Magnetic Resonance Angiography (2003) (14)
Dendron based antifouling, MRI and magnetic hyperthermia properties of different shaped iron oxide nanoparticles (2019) (14)
Fluorinated MRI contrast agents and their versatile applications in the biomedical field. (2019) (14)
Synthesis and characterization of a new lanthanide based MRI contrast agent, potential and versatile tracer for multimodal imaging (2014) (14)
Characterization of Gd loaded chitosan-TPP nanohydrogels by a multi-technique approach combining dynamic light scattering (DLS), asymetrical flow-field-flow-fractionation (AF4) and atomic force microscopy (AFM) and design of positive contrast agents for molecular resonance imaging (MRI) (2017) (13)
Embedding of superparamagnetic iron oxide nanoparticles into membranes of well-defined poly(ethylene oxide)-block-poly(ε-caprolactone) nanoscale magnetovesicles as ultrasensitive MRI probes of membrane bio-degradation. (2019) (13)
Antioxidant Activity and a New Ursane-type Triterpene from Vitellaria paradoxa (Sapotaceae) Stem Barks (2016) (13)
Blocked-micropores, surface functionalized, bio-compatible and silica-coated iron oxide nanocomposites as advanced MRI contrast agent (2013) (13)
Potential theranostic and multimodal iron oxide nanoparticles decorated with rhenium-bipyridine and -phenanthroline complexes. (2015) (13)
Synthesis and physicochemical characterization of Gd-C4-thyroxin-DTPA, a potential MRI contrast agent. Evaluation of its affinity for human serum albumin by proton relaxometry, NMR diffusometry, and electrospray mass spectrometry. (2010) (13)
Functionalization of the PEG Corona of Nanoparticles by Clip Photochemistry in Water: Application to the Grafting of RGD Ligands on PEGylated USPIO Imaging Agent. (2015) (13)
Slow clearance gadolinium‐based extracellular and intravascular contrast media for three‐dimensional MR angiography (2001) (12)
Influence of experimental parameters on iron oxide nanoparticle properties synthesized by thermal decomposition: size and nuclear magnetic resonance studies. (2018) (12)
Screening for peptides targeted to IL-7Rα for molecular imaging of rheumatoid arthritis synovium (2016) (12)
Thermodynamic stability and kinetic inertness of a Gd-DTPA bisamide complex grafted onto gold nanoparticles. (2015) (12)
Developmental toxicity of iron oxide nanoparticles with different coatings in zebrafish larvae (2020) (12)
Bifunctional Gd(III) and Tb(III) chelates based on a pyridine-bis(iminodiacetate) platform, suitable optical probes and contrast agents for magnetic resonance imaging. (2014) (12)
The Gd3+ complex of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid mono(p-isothiocyanatoanilide) conjugated to inulin: a potential stable macromolecular contrast agent for MRI. (2011) (12)
Evaluation of the Active Targeting of Melanin Granules after Intravenous Injection of Dendronized Nanoparticles. (2018) (11)
Albumin-bound MRI contrast agents: the dilemma of the rotational correlation time (2001) (11)
Magnetofluorescent micelles incorporating Dy(III)-DOTA as potential bimodal agents for optical and high field magnetic resonance imaging. (2016) (11)
Imaging of Human Insulin Secreting Cells with Gd-DOTA-P88, a Paramagnetic Contrast Agent Targeting the Beta Cell Biomarker FXYD2γa (2018) (11)
Washing effect on superparamagnetic iron oxide nanoparticles (2016) (11)
Lanthanide complexes on Ag nanoparticles: designing contrast agents for magnetic resonance imaging. (2009) (11)
CMR2009: 5.08: Structure–HSA affinity relationship of some new Gd‐DTPA derivatives (2009) (11)
Mn2+ Complexes with Pyclen-Based Derivatives as Contrast Agents for Magnetic Resonance Imaging: Synthesis and Relaxometry Characterization. (2021) (11)
A glycosylated complex of gadolinium, a new potential contrast agent for magnetic resonance angiography? (2007) (10)
Unveiling the role of surface, size, shape and defects of iron oxide nanoparticles for theranostic applications. (2021) (10)
Synthesis and Physicochemical Characterization of New C-Functionalized Derivatives of the Gadolinium(III) Complex with 3,6,10-Tris(carboxymethyl)-3,6,10-triazadodecanedioic Acid (H5ttda) Exhibiting Fast Water Exchange – Potential Paramagnetic Reporters for Molecular Imaging (2007) (10)
How a grafting anchor tailors the cellular uptake and in vivo fate of dendronized iron oxide nanoparticles. (2017) (10)
Optimizing Water Exchange Rates and Rotational Mobility for High‐Relaxivity of a Novel Gd‐DO3A Derivative Complex Conjugated to Inulin as Macromolecular Contrast Agents for MRI (2018) (10)
Anti-Inflammatory and Analgesic Effect of Arachic Acid Ethyl Ester Isolated from Propolis (2020) (10)
Tailored ultra-small Prussian blue-based nanoparticles for MRI imaging and combined photothermal/photoacoustic theranostics. (2019) (10)
Ultrasound-targeted microbubble destruction: toward a new strategy for diabetes treatment. (2016) (10)
Deuterium NMR study of the MP-2269: albumin interaction — a step forward to the dynamics of non-covalent binding (2001) (10)
Reinvestigation of the mechanism of polymerization of β-butyrolactone from 1,5,7-triazabicyclo[4.4.0]dec-5-ene (2018) (9)
Correlation between physicochemical properties of superparamagnetic iron oxide nanoparticles and their reactivity with hydrogen peroxide (2020) (9)
Medical Applications of Metallic Bismuth Nanoparticles (2021) (9)
Prevalence, management and ethnobotanical investigation of hypertension in two Guinean urban districts. (2019) (9)
Ethnomedical, Phytochemical and Biological Investigations of Margaritaria discoidea (Baill.) Webster, a Plant Species Widely Used in Guinean Traditional Medicine (2014) (9)
A New fatty acid and some triterpenoids from propolis of Nkambe (North-West Region, Cameroon) and evaluation of the antiradical scavenging activity of their extracts (2020) (9)
Magnetofluorescent Nanoaggregates Incorporating Terbium(III) Complexes as Potential Bimodal Agents for Magnetic Resonance and Optical Imaging (2015) (8)
Interaction of iron(II)-heme and artemisinin with a peptide mimic of Plasmodium falciparum HRP-II. (2007) (8)
Vitellaroside, A New Cerebroside from Vitellaria paradoxa (Sapotaceae) and its Bioactivities (2018) (8)
Synthesis and characterization of new low-molecular-weight lysine-conjugated Gd-DTPA contrast agents. (2010) (8)
Early detection of colonic dysplasia by magnetic resonance molecular imaging with a contrast agent raised against the colon cancer marker MUC5AC. (2016) (8)
Bimodal Probe for Magnetic Resonance Imaging and Photoacoustic Imaging Based on a PCTA-Derived Gadolinium(III) Complex and ZW800-1 (2019) (8)
Validation by Magnetic Resonance Imaging of the Diagnostic Potential of a Heptapeptide-Functionalized Imaging Probe Targeted to Amyloid-β and Able to Cross the Blood-Brain Barrier. (2017) (8)
NMR determination of free gallium(III) ions in aqueous solutions of Ga complexes, "cold" analogs of PET/SPECT tracers. (2011) (8)
Simultaneous “O–Alkyl” and “O–Acyl” Lactone Cleavages from Hydroxy–Carboxylic Acid Initiators: Direct Access to Multiblock Architectures (2019) (7)
Relaxometric, Thermodynamic and Kinetic Studies of Lanthanide(III) Complexes of DO3A-based Propylphosphonates (2009) (7)
DPPH antiradical scavenging, anthelmintic and phytochemical studies of Cissus poulnea rhizomes (2018) (7)
Myeloid tumor necrosis factor and heme oxygenase‐1 regulate the progression of colorectal liver metastases during hepatic ischemia‐reperfusion (2020) (7)
Superparamagnetic Iron Oxide Nanoparticles (SPION): From Fundamentals to State-of-the-Art Innovative Applications for Cancer Therapy (2023) (6)
Targeted Iron Oxide (Nano)particles Used as MRI Contrast Agent in Small Animal Models (2018) (6)
Development of an LDL Receptor-Targeted Peptide Susceptible to Facilitate the Brain Access of Diagnostic or Therapeutic Agents (2020) (6)
Flying Cages in Traveling Wave Ion Mobility: Influence of the Instrumental Parameters on the Topology of the Host–Guest Complexes (2017) (6)
Protein Corona: Applications and Challenges (2013) (6)
Comparison of MRI Properties between Multimeric DOTAGA and DO3A Gadolinium-Dendron Conjugates. (2019) (6)
Formation and identification of ionized and neutral cumulenes, RNCCCNH, by tandem mass spectrometry (1993) (6)
Chemical and in vitro characterizations of a promising bimodal AGuIX probe able to target apoptotic cells for applications in MRI and optical imaging. (2016) (6)
Drawing on biology to inspire molecular design: a redox-responsive MRI probe based on Gd(iii)-nicotinamide. (2018) (6)
New polyaminocarboxylate macrocycles containing phenolate binding units: synthesis, luminescent and relaxometric properties of their lanthanide complexes. (2017) (6)
Noncovalent Binding of Some New Lipophilic Gadolinium DTPA Complexes to Human Serum Albumin. A Structure–Affinity Relationship (2010) (5)
Nanodiamonds as nanomaterial for biomedical field (2021) (5)
Impact of the chain length on the biodistribution profiles of PEGylated iron oxide nanoparticles: a multimodal imaging study. (2021) (5)
Contrast Agents for MRI: Recent Advances (2009) (5)
Synthesis, crystal structures and electronic properties of isomers of chloro-pyridinylvinyl-1H-indoles. (2012) (5)
Design, Characterization and Molecular Modeling of New Fluorinated Paramagnetic Contrast Agents for Dual 1H/19F MRI (2020) (5)
A new abietane-type diterpenoid from roots of Burkea africana Hook (Fabaceae) with α-amylase inhibitory potential (2021) (5)
Rheological Properties of Superparamagnetic Iron Oxide Nanoparticles (2021) (5)
Chapter 4:Iron-oxide Nanoparticle-based Contrast Agents (2017) (5)
Structure of CoFe2O4@CdTe nanocomposite with core/shell structure for high-performance Bi-modal imaging (2018) (4)
Hepatocarcinoma Induces a Tumor Necrosis Factor-Dependent Kupffer Cell Death Pathway That Favors Its Proliferation Upon Partial Hepatectomy (2020) (4)
Optical and relaxometric properties of monometallic (Eu(III), Tb(III), Gd(III)) and heterobimetallic (Re(I)/Gd(III)) systems based on a functionalized bipyridine-containing acyclic ligand. (2016) (4)
Analytical Methods for Corona Evaluations (2013) (4)
Synthesis and properties of a functionalized heterobimetallic Re(I)–Gd(III) complex as a potential dual-contrast agent for molecular imaging (2013) (4)
Interaction between iron oxide nanoparticles and HepaRG cells: a preliminary in vitro evaluation (2015) (4)
Preliminary studies of 68Ga-NODA-USPION-BBN as a dual-modality contrast agent for use in positron emission tomography/magnetic resonance imaging (2019) (4)
Synthesis of Isoxazolo[4,5-D]Pyrimidinones, and Their Isomerization Into Oxazolo[4,5-D]Pyrimidinones On Flash Vacuum Pyrolysis (2010) (4)
Supramolecular adducts of negatively charged lanthanide(III) DOTP chelates and cyclodextrins functionalized with ammonium Groups: Mass spectrometry and nuclear magnetic resonance studies (2012) (4)
Toward a new and noninvasive diagnostic method of papillary thyroid cancer by using peptide vectorized contrast agents targeted to galectin-1 (2017) (4)
Antimicrobial and α-glucosidase inhibitory activities of chemical constituents from Gardenia aqualla (Rubiaceae) (2022) (4)
Novel molecular targeted and wide spectrum antitumor agents: Preparation and preclinical evaluation of IER5/Cdc25B targeted low-molecular-weight phospha sugar derivatives (2016) (4)
Synthesis of CdTe QDs by hydrothermal method, with tunable emission fluorescence (2015) (4)
Toxic Effects of Nanomaterials (2012) (4)
Multinuclear MR characterization of a new hepatobiliary contrast agent. Preliminary results. (1997) (4)
A new flavonoid glycoside from Tapinanthus sp. (Loranthaceae) and evaluation of anticancer activity of extract and some isolated compounds (2021) (4)
The combination of an innovative dry powder for inhalation and a standard cisplatin-based chemotherapy in view of therapeutic intensification against lung tumours. (2021) (4)
CONTROLLING THE BURST EFFECT OF A DRUG BY INTRODUCING STARCH IN THE STRUCTURE OF MAGNETIC POLYURETHANE MICROSPHERES CONTAINING SUPER PARAMAGNETIC IRON OXIDE NANOPARTICLES (2010) (4)
Magnetic and radio-labeled bio-hybrid scaffolds to promote and track in vivo the progress of bone regeneration. (2021) (3)
Interaction of bare and gold-coated superparamagnetic iron oxide nanoparticles with fetal bovine serum (2011) (3)
Synthesis and Relaxometric Characterization of New Poly[N,N‐bis(3‐aminopropyl)glycine] (PAPGly) Dendrons Gd‐Based Contrast Agents and Their in Vivo Study by Using the Dynamic Contrast‐Enhanced MRI Technique at Low Field (1 T) (2019) (3)
Polymeric/Inorganic Multifunctional Nanoparticles for Simultaneous Drug Delivery and Visualization (2010) (3)
A Greener Chemistry Process Using Microwaves in Continuous Flow to Synthesize Metallic Bismuth Nanoparticles (2021) (3)
RICH EXTRACT ON TOTAL POLYPHENOLS AND ANTIOXIDANT ACTIVITY OBTAINED BY CONVENTIONAL AND NON-CONVENTIONAL METHODS FROM AHMEUR BOUAMER GRAPE SEED (2018) (3)
Preparation and Evaluation of Novel Sugar Dendritic Gd-DTPA Complexes for MRI Contrast Agents and Phospha Sugars for Anti-Tumour Agents (2011) (3)
An α-Sophoradiol Glycoside from the Root Wood of Erythrina senegalensis DC. (Fabaceae) with α-Amylase and α-Glucosidase Inhibitory Potential (2021) (3)
Pyclen-based Gd complex with ionisable side-chain as a contrastophore for the design of hypersensitive MRI nanoprobes: synthesis and relaxation studies (2021) (3)
Molecular Imaging of Galectin-1 Expression as a Biomarker of Papillary Thyroid Cancer by Using Peptide-Functionalized Imaging Probes (2020) (3)
Two new compounds from stem barks of Vepris heterophylla ( Engl . ) R . Let . ( Rutaceae ) (2015) (3)
Fluorometry, a fast screening technique for non-covalent binding of contrast agents to human serum albumin? (2013) (3)
Fluorescent chitosan-based nanohydrogels and encapsulation of gadolinium MRI contrast agent for magneto-optical imaging (2021) (3)
Side-chain loss reactions of collisionally activated protonated peptoids: A mechanistic insight (2019) (3)
Effect of nonenzymatic glycosylation on the magnetic resonance imaging (MRI) contrast agent binding to human serum albumin. (2012) (3)
Synthesis and characterization of monophosphinic acid DOTA derivative: A smart tool with functionalities for multimodal imaging. (2017) (3)
Synthesis and Physicochemical Characterization of Gd-DTPA Derivatives as Contrast Agents for MRI (2012) (2)
Improving stabilization and responsiveness of iron oxide nanoparticles with a triblock copolymer (2015) (2)
Development of a molecular approach for the monitoring and treatment of diabetic patients (2015) (2)
Galectin-1, a potential molecular imaging biomarker of well-differentiated thyroid cancers (2015) (2)
AGuIX® nanoparticles vectorization for an apoptosis targeting (2013) (2)
Development of a new diagnosis approach by MRI of papillary thyroid cancer using a vectorized contrast agent directed against galectin-1 (2015) (2)
Optimised Synthetic Route for Tuneable Shell SiO2@Fe3O4 Core-Shell Nanoparticles (2008) (2)
Polysiloxane coated nanoparticles, an innovative platform for bimodal molecular imaging (2015) (2)
Design and characterization of paramagnetic dendrimer intended for molecular imaging (2012) (2)
New multimodal platforms of nanodiamond for molecular imaging (2013) (2)
Chemical and Biological Characterizations of an Effective Bimodal Probe to Target Apoptosis (2015) (2)
Cell Life Cycle Effects of Bare and Coated Superparamagnetic Iron Oxide Nanoparticles (2012) (2)
Nano-thermometer with Thermo-sensitive Polymer Grafted USPIOs behaving as Positive Contrast Agents in low-field MRI (2013) (2)
Preliminary studies of 68Ga-NODA-USPION-BBN as a dual modality contrast agent using in PET/MRI. (2019) (2)
Superparamagnetic iron oxide nanoparticles (SPIONs): Development, surface modification, and applications in drug delivery (2014) (2)
Uptake of tritiated liquids by individual breakfast cereal flakes. (2010) (2)
Imaging: High Relaxivities and Strong Vascular Signal Enhancement for NaGdF4 Nanoparticles Designed for Dual MR/Optical Imaging (Adv. Healthcare Mater. 11/2013) (2013) (2)
In Vitro Evaluation of α-amylase and α-glucosidase Inhibition of 2,3-Epoxyprocyanidin C1 and Other Constituents from Pterocarpus erinaceus Poir (2022) (2)
Proton MRD Profile Analysis in Intracellular Hemoglobin Solutions: A Three Sites Exchange Model Approach (2022) (2)
Novel Polymeric Micelles-Coated Magnetic Nanoparticles for In Vivo Bioimaging of Liver: Toxicological Profile and Contrast Enhancement (2020) (2)
AGuIX® nanoparticles grafting for a selective targeting of apoptotic cells (2013) (2)
Surface engineering of silica nanoparticles with a gadolinium–PCTA complex for efficient T1-weighted MRI contrast agents (2020) (2)
Paramagnetic Gadolinium Complexes (2017) (2)
Synthesis and manifold physicochemical characterization of a new gadolinium complex with a high affinity for human serum albumin (2008) (2)
This thesis is based on following publications : (2010) (2)
Bioconjugation studies of an EGF-R targeting ligand on dendronized iron oxide nanoparticles to target head and neck cancer cells. (2023) (2)
Characterization of new diimines of carbon suboxide by tandem mass spectrometry (1994) (2)
Self-assembly of poly(ethylene oxide)-block-poly(ε-caprolactone) copolymers with iron oxide nanoparticles for potential drug delivery and magnetic resonance imaging applications (2016) (2)
Relaxometric NMR studies of the interaction between MRI paramagnetic contrast agents grafted to selected peptides with micellar models of apoptotic cells (2015) (2)
Nano Delivery Systems (2018) (2)
Synthesis and characterization of Gd-C4-thyroxin-DTPA, a potential new MRI contrast agent. Study of its non covalent interaction with human serum albumin (2009) (2)
Backbone Cleavages of Protonated Peptoids upon Collision-Induced Dissociation: Competitive and Consecutive B-Y and A1-YX Reactions (2019) (2)
Stageing of Atherosclerotic Plaques by a Vascular Cell Adhesion Protein-1 Targeted Contrast Agent (2011) (2)
Specific strategy of thyroïd cancer diagnosis by galectin-1 targeting (2015) (2)
Monodisperse Water-Soluble Superparamagnetic Iron Oxide Nanoparticles Revealed as High-Performance T2 Contrast Agents (2007) (2)
NMR chemical shift study of the interaction of selected peptides with liposomal and micellar models of apoptotic cells (2014) (2)
Design and synthesis of MRI contrast agents dedicated to the Imaging of the central nervous system (2013) (2)
Dual paclitaxel/superparamagnetic iron oxide-loaded PLGA-based nanoparticles for cancer therapy and magnetic resonance imaging (2012) (2)
Development and validation of a peptide-vectorized superparamagnetic imaging probe designed for the detection of inflammation in atherosclerotic plaque (2010) (2)
Characterization of commercial iron oxide clusters with high transverse relaxivity (2022) (2)
Magnetic Polymersomes for MRI and Theranostic Applications (2018) (2)
Antifungal potential of extracts, fractions and compounds from Uvaria comperei (Annonaceae) and Oxyanthus unilocularis (Rubiaceae) (2020) (1)
Controlling the Burst E ect of a Drug by Introducing Starch in the Structure of Magnetic Polyurethane Microspheres Containing Superparamagnetic Iron Oxide Nanoparticles (2010) (1)
Ef fi cient internalization of silica-coated iron oxide nanoparticles of different sizes by primary human macrophages and dendritic cells (2011) (1)
Front Cover: Bimodal Probe for Magnetic Resonance Imaging and Photoacoustic Imaging Based on a PCTA-Derived Gadolinium(III) Complex and ZW800-1 (Eur. J. Inorg. Chem. 29/2019) (2019) (1)
A new phenyl alkyl ester and a new combretin triterpene derivative from Combretum fragrans F. Hoffm (Combretaceae) and antiproliferative activity (2020) (1)
Molecular Imaging of Angiogenic Blood Vessels in Vulnerable Atherosclerotic Plaques with a Mimetic of RGD Peptide Grafted to Gd-DTPA (2011) (1)
Primary and secondary structures of peptoids as probed by Ion Mobility Mass Spectrometry (2018) (1)
Metal-Based Systems for Molecular Imaging Applications (2009) (1)
Characterization of Gd loaded chitosan-TPP nanohydrogels (2016) (1)
Hypersensitive systems for T1 MR imaging: structuration of the water pocket around Gd chelates (2017) (1)
Accelerating effect of crown ethers on the lactide polymerization catalysed by potassium acetate (2021) (1)
The Size, Shape, and Composition Design of Iron Oxide Nanoparticles to Combine, MRI, Magnetic Hyperthermia, and Photothermia (2021) (1)
osition of biocompatible Gd nanohydrogels to achieve hypersensitive dual T 1 / T 2 MRI contrast agents † (2014) (1)
Development of a galectin-1 targeted contrast agent for the MRI diagnosis of papillary thyroid cancer (2015) (1)
Effect of the Size and Shape of Dendronized Iron Oxide Nanoparticles Bearing a Targeting Ligand on MRI, Magnetic Hyperthermia, and Photothermia Properties—From Suspension to In Vitro Studies (2023) (1)
PEGylated very-small iron oxide nanoparticles (VSION) as positive contrast agents for magnetic resonance imaging (MRI) (2018) (1)
Synthesis and characterization of successive generations of paramagnetic dendrimers. Evaluation and perspectives (2016) (1)
R&D of novel medicinal materials for curing cancer: sugar modified Gd-DTPA MRI contrast agents and phospha sugar anti-cancer agents (2009) (1)
Two New Cycloartenol and Some Pentacyclic Triterpenoids from Cameroonian Propolis (Ngaoundal, AD Region) and Evaluation of their Antimicrobial Activity (2021) (1)
A modular approach towards the synthesis of targeted MRI contrast agents (2011) (1)
Heterophynone and methyl ester of Colic acid, two new compounds with antimicrobial activity from Cola heterophylla (Sterculiaceae) (2020) (1)
Two new flavones glycosides with antimicrobial activities from Clerodendrum formicarum Gürke (Lamiaceae) (2019) (1)
Cellular Magnetic Labeling with Iron Oxide Nanoparticles (2011) (1)
Interest of Nanomaterials in Medicine (2017) (1)
CMR 2005: 12.04: Stealthy magnetophages, a new tool for molecular imaging (2006) (1)
Molecular Signal of Nitrogen Starvation, Insight from the Cyanobacterium Anabaena PCC 7120 (2005) (1)
Dual-Modality Imaging (2018) (1)
Antibacterial and antioxidant activities and phytochemical composition of Stereospermum kunthianum root bark (2021) (1)
The targeting of phospholipase signaling and of LDL receptor aiming to develop a new therapeutic approach for Alzheimer's disease management (2015) (1)
Inhibitors Mechanistic Insight into Heptosyltransferase Inhibition by using Kdo Multivalent (2016) (1)
General Theory of the Relaxivity of Particulate Contrast Agents (2018) (1)
Modulation of adiponectin receptors AdipoR1 and AdipoR2 by phage display-derived peptides in in vitro and in vivo models (2019) (1)
Vascular cell adhesion molecule-1 targeted nanoparticles discriminate between atherosclerotic plaque stages in disease progression and therapy (2013) (1)
Probing the secondary structure of peptoid foldamers by combining Mass Spectrometry, Nuclear Magnetic Resonance, Circular Dichroism and computational chemistry (2017) (1)
Effects of novel galectin-1-targeted peptides on human cells in the context of a new and non-invasive thyroid cancer diagnosis (2016) (1)
coated iron oxide nanoparticles: a convenient platform for cellular and small animal imaging† (2014) (1)
Biocompatible nanohydrogels incorporating conventional MRI contrast agents : simple design, huge performances (2016) (1)
Innovative contrast agent for neurodegenerative disease diagnosis (2017) (1)
Tumor Targeting by RGD-Grafted PLGA-Based Nanotheranostics Loaded with Paclitaxel and Superparamagnetic Iron Oxides (2015) (1)
Chemical Constituents of Crossopteryx febrifuga (Afzel ex G. Don) Benth (Rubiaceae), their Phytotoxicity and Antioxidant Activities (2021) (1)
Improving stabilization and responsiveness of superparamagnetic iron oxide nanoparticles with a triblock copolymer (2015) (1)
Synthesis and Characterization of Conjugated Hyaluronic Acids. Application to Stability Studies of Chitosan-Hyaluronic Acid Nanogels Based on Fluorescence Resonance Energy Transfer (2022) (1)
Technical issues of Fast Field Cycling NMR Relaxometry (2005) (1)
Peptide-mediated modulation of a phospholipase isoform and blood-brain barrier transcytosis in the context of Alzheimer’s disease therapy (2016) (1)
CMR 2007: 7.07: Hybrid gadolinium oxide nanoparticles: contrast agents combining diagnosis and therapy (2007) (1)
The Biological Significance of “Nano”-interactions (2013) (1)
Targeting of cell death and neuroinflammation with peptide-linked iron oxide nanoparticles and Gd-DTPA in a mouse model of Parkinson's disease (2015) (1)
A new phenanthrene derivative from Entada abyssinica with antimicrobial and antioxidant properties (2021) (0)
Blood-brain barrier crossing for improving brain access using a peptide able to bind a receptor-mediated transcytosis (2017) (0)
Editorial for “New Cluster Analysis Method for Quantitative DCE‐MRI Assessing Tumor Heterogeneity Induced by E7130 Treatment to a Breast Cancer Mouse Model” (2022) (0)
Lanthanides: Magnetic Resonance Imaging (2012) (0)
Targeting amyloid plaques for the early diagnosis of Alzheimer’s disease: validation of a vectorized superparamagnetic contrast agent able to cross the blood-brain barrier (2016) (0)
A fluorinated paramagnetic contrast agent : synthesis, physicochemical characterization and perspectives (2017) (0)
The phospholipase A2 signaling as a new therapeutic biomarker of Alzheimer’s disease: modulation through phage display-derived peptides able to cross the blood-brain barrier (2017) (0)
Synthesis of a bimodal contrast agent for magnetic resonance imaging and photoacoustic imaging (2019) (0)
Synthesis of gadolinium complexes for the detection of atherosclerotic plaques by magnetic resonance and optical imaging (2018) (0)
Novel contrast agents based on pyclen derivative manganese complexes to be incorporated inside polymersomes (2020) (0)
Imaging the Distribution of High Colloidal Stability Mesoporous Silica Nanoparticles (MSNs) with PET and MRI (2013) (0)
Toxicity of TiO2 nanoparticles on the NRK52E renal cell line (2017) (0)
Efficacy and Nephrotoxicity Assessment of Cisplatin-based Regimens Combining an Innovative Dry Powder for Inhalation and Intravenous route (2020) (0)
Proton MRD Profile Analysis in Intracellular Hemoglobin Solutions: A Three Sites Exchange Model Approach (2022) (0)
Dual H/F MRI Contrast Agents: synthesis, physico-chemical characterizations and molecular dynamic simulations (2019) (0)
Paramagnetic liposomes, inner and outer vesicle relaxivity (2005) (0)
" Chiral recognition of peptoid selector toward chiral drugs: deciphering the gas phase conformation of ionized peptoids by liquid chromatography and ion mobility " (2016) (0)
Backbone Cleavages of Protonated Peptoids upon Collision-Induced Dissociation: Competitive and Consecutive B-Y and A1-YX Reactions. (2019) (0)
Washing effect on super paramagnetic iron oxide nanoparticles (2016) (0)
Development of small-sized iron oxide nanoparticles for T1-weighted magnetic resonance imaging (MRI) (2017) (0)
Lanthanide Nanoparticles for Medical Imaging (2013) (0)
Clustering of iron oxide nanoparticles into poly(ethylene oxide)-block-poly(ε-caprolactone) nanoassemblies as ultrasensitive MRI probes (2016) (0)
Preparation of thermoresponsive diblock and copolymers by RAFT polymerization for the stabilization of SPIONs as potent contrast agents (2016) (0)
Protontherapy for head and neck cancer (2019) (0)
Tracing neuronal pathways by MRI using WGA coated iron oxide nanoparticles (2004) (0)
Chapter 17:Paramagnetic Complexes and Superparamagnetic Systems (2018) (0)
Development of a nanoparticulate T1 contrast agent for magnetic resonance imaging (2016) (0)
SYNTHESIS, ACTIVITY, CRYSTAL AND ELECTRONIC PROPERTIES OF ISOMERS OF CHLORO-PYRIDINYLVINYL-1H-INDOLES (2011) (0)
Synthesis and characterisation of fluorinated paramagnetic contrast agents for their use in F-19 MRI (2016) (0)
Synthesis of magnetic dendrimer for the detection of atherosclerotic plaques (2017) (0)
Characterization of Organic Molecules Grafted to Silica or Bismuth Nanoparticles by NMR (2021) (0)
Thematic Session: Nano for imaging, diagnosis and theranostics Keywords: Chitosan, Hyaluronic acid, Nanohydrogel, Functionalization, MRI, optical imaging Fluorescent biocompatible nanohydrogels for Gd chelates encapsulation: polymer design, nanogel syntheses and in vitro evaluation of the resulting (2019) (0)
From SiO precursor to bimodal probe : An innovative way to target inflammation (2017) (0)
Toward bimodal imaging through PCTA scaffold-based complexes (2016) (0)
TLVSSL peptide grafted on ultrasmall rigid platforms as multimodal probes for biomedical applications (2011) (0)
Synthesis, characterization, and relaxation studies of a fluorinated paramagnetic contrast agent for a future use in 19F MRI (2017) (0)
Fluorinated paramagnetic contrast agents – study of the paramagnetic effect from diverse lanthanide ions (Gd3+, Dy3+, Tb3+, Eu3+) on fluorine relaxation times (2019) (0)
Synthesis , crystal structures and electronic properties of isomers of chloro-pyridinylvinyl-1 H-indoles (2012) (0)
Impact of 99mTc-labelling on binding and viability of human adipose tissue-derived cells in vitro and on the cell-tracking properties using SPECT in vivo (2016) (0)
Development of Superparamagnetic Particles Dispersions Basic Materials of Markers for Molecular Imaging (2005) (0)
Development of a continuous flow reactor for the synthesis of small-sized iron oxide nanoparticles active as T1 contrast agents for magnetic resonance imaging (MRI) (2017) (0)
A new class of paramagnetic contrast agents: synthesis, characterizations and relaxation studies of a fluorinated paramagnetic contrast agent (2018) (0)
A New Multimodal Platform to Obtain a Versatile and Targeted MRI and Photoacoustic Contrast Agent (2019) (0)
Discrimination of Regioisomeric and Stereoisomeric Saponins from Aesculus hippocastanum Seeds by Ion Mobility Mass Spectrometry. (2019) (0)
Papillary thyroid cancer diagnostic by galectin-1 targeting using peptide vectorized contrast agent for MRI (2016) (0)
Fluorinated paramagnetic contrast agent : synthesis, characterization and relaxation studies (2017) (0)
Synthesis, structural, enzymatic and cellular studies of vinyl-1H-indole analogues as potential inhibitors of tryptophan 2,3-dioxygenase (TDO), an attractive target in cancer immunotherapy. (2011) (0)
Synthesis and relaxometric characterization of MRI contrast agents based on pyclen structure and complexed with manganese. (2019) (0)
Biocompatibility of tuneable silica shell-magnetic core nanoparticles evaluated in vitro using primary human monocute-derived macrophages (2010) (0)
Synthesis of a dendritic platform bearing four tetraazamacrocyclic ligands for atherosclerosis plaque imaging (2019) (0)
Dual-modality probe for MRI and photoacoustic imaging: synthesis, and relaxometric characterization (2018) (0)
CHAPTER 7 Dual-Modality Imaging (2017) (0)
Luminescence and relaxometric properties of LnIII complexes derived from macrocyclic PCTA ligand : impact of replacing a pyridine ring by a phenolate moiety (2017) (0)
Future probe for neurodegenerative disease diagnosis (2017) (0)
PCSK9 gene variants in west – African type 2 diabetes mellitus (T2DM) patients (2019) (0)
Secondary structure of ionized peptoids by Ion Mobility Mass Spectrometry: Influence of the basic terminal group and the side chain (2018) (0)
Study of the interaction between Sialyl Lewisx mimetic and E-selectin: A new way to target inflammation? (2016) (0)
Design of an effective bimodal diamond-based nanoprobe for biomedical purposes (2016) (0)
CMR 2007: 8.01: A comprehensive study of the charge–water exchange rate relationship in a series of Gd-DTPA derivatives, potential MRI contrast agents (2007) (0)
Interdisciplinary Challenges and Promising Theranostic Effects of Nanoscience in Alzheimer′s Disease (2012) (0)
Design of Vectorized Nanodiamond as Contrast Agent for Prepolarized MRI at Earth Field: PrimoGAIA project (2020) (0)
Development of a multimodal contrast agent for MRI and PET applications (2017) (0)
Advances in the Mechanistic Understanding of Iron Oxide Nanoparticles’ Radiosensitizing Properties (2023) (0)
Small-sized iron oxide nanoparticles as potential theranostic agents for MRI and protontherapy (2017) (0)
Critical parameters to translate gold nanoparticles as radiosensitizing agents into the clinic. (2023) (0)
Development of an original phospholipase A2-targeted peptide able to reduce amyloid pathology in a mouse model of Alzheimer’s disease (2019) (0)
Development of a new therapeutic approach for Alzheimer's disease by phospholipase pathway modulation and blood-brain barrier shuttling (2015) (0)
Collision-induced dissociation of protonated peptoids: distinction between rearrangement and cleavage mechanisms (2017) (0)
E-selectin targeted MRI visualizes progression of atherosclerotic plaques (2013) (0)
Titre : Title : Charge effect of superparamagnetic iron oxide nanoparticles on their surface functionalization by photo-initiated chemical vapour deposition (2017) (0)
Synthesis and characterization of a nanoparticulate T1 contrast agent for magnetic resonance imaging (2016) (0)
Identification of Peptide Ligands that Target Apoptotic Cells by Means of Specific Interactions with Phosphatidylserine. Applications to Molecular Imaging by MRI (2009) (0)
Synthesis of Iron Oxide Nanoparticles (2018) (0)
Nanohydrogels-Based Hypersensitive MRI Probes: Synthesis and Functionalization (2018) (0)
Bimodal nanodiamond platform designed for medical imaging: surface thermal treatment and coupling with specific agents (2016) (0)
Vrije Universiteit Brussel Hepatocarcinoma induces a tumor necrosis factor-dependent Kupffer cell death pathway that favors its proliferation upon partial hepatectomy Hastir, (2020) (0)
A novel therapeutic strategy for Alzheimer’s disease: utility of peptides targeting phospholipase A2 and able to cross the blood-brain barrier through the LDL receptor (2018) (0)
Cover Picture: Synthesis and Relaxometric Characterization of New Poly[ N , N ‐bis(3‐aminopropyl)glycine] (PAPGly) Dendrons Gd‐Based Contrast Agents and Their in Vivo Study by Using the Dynamic Contrast‐Enhanced MRI Technique at Low Field (1 T) (C&B 11/2019) (2019) (0)
Ultrasmall particle of iron oxide - RGD peptidomimetic conjugate as novel MRI contrast agent (2010) (0)
Iminoethenone Radical Cations (RN=C=C=O×+): Tandem Mass Spectrometry and ab initio MO Studies (1994) (0)
Innovative and Strategic Materials against Various Kinds of Tumor Cells: Preclinical Research on Sugar Dendritic Gd-DTPA Complex MRI Contrast Agents and IER5/Cdc25B Targeted Novel Low-molecular-weight Phospha Sugar Antitumor Agents (2016) (0)
Tailorable magnetic coordination nanoparticles : from information storage to biomedical applications (2016) (0)
Development of silica nanoparticles for 1H MRI and optical imaging (2019) (0)
Synthesis and characterization of paramagnetic dendrimers for the detection of atherosclerotic plaque by MRI and optical imaging (2020) (0)
L’expérimentation animale reste indispensable (OPINION) (2017) (0)
Organic nanoparticles and gadolinium chelates: seeking hypersensitive probes for T1 magnetic resonance imaging (2019) (0)
PEPTIDE AGONISTS OF ADIPONECTIN RECEPTORS 1 AND 2 (2018) (0)
MRI T2 WEIGHTED THERANOSTIC NANODEVICES AND CHEMOTHERAPY (2016) (0)
1H‐NMR relaxometric studies of interaction between apoptosis specific MRI paramagnetic contrast agents and micellar models of apoptotic cells (2016) (0)
method of treating insects comprising the separation of the cuticles of the soft part of the insects and the separation of the soft part in three fractions (2016) (0)
71 poster: Iron Oxide Particles Covered with Hexapeptides Targeted at Phosphatidylserine as MR Biomarkers of Tumor Cell Death (2010) (0)
Preclinical Researches on Tumor Acumulative and Remarkably Higher Sensitive Novel Sugar Dendritic Gd-DTPA Complex MRI Contrast Agents (2019) (0)
New therapeutic management of Alzheimer’s disease: interest to a phospholipase A2-targeted peptide able to cross the blood-brain barrier through the LDL receptor (2016) (0)
MRI Applications: Classification According to Their Biodistribution (2017) (0)
A New Active and Specific Diamond Nanoprobe Designed for Medical Imaging Applications (2016) (0)
Galectin-1 binding peptides and use thereof for diagnostic and therapeutic purpose (2017) (0)
A Nanoparticle Ink Allowing the High Precision Visualization of Tissue Engineered Scaffolds by MRI. (2023) (0)
Chemical Constituents and Biological Activities of the Aerial Parts of Cyperus rotundus (Cypereaceae) (2021) (0)
Development of a bimodal contrast agent for MRI and PET scan (2016) (0)
Functionalizable multimeric gadolinium DOTAGA and DO3A dendron conjugates for the detection of atherosclerotic plaques (2019) (0)
Synthesis of N-fluoroalkyl-tryptophan and study of their biological activity as potential substrates for indoleamine 2,3-dioxygenase (2014) (0)
Synthesis of Paramagnetic Dendrimers for MRI (2019) (0)
PEGylated iron oxide nanoparticles: evidence of their potential as T1 contrast agents for magnetic resonance imaging (2019) (0)
Knockdown of CSNK1D affect migratory capacity of triple negative cell lines (2017) (0)
Impact of RAFT chain transfer agents on the polymeric shell density of magneto-fluorescent nanoparticles and their cellular uptake. (2022) (0)
Nanohydrogels and Gadolinium Chelates: Functionnalizable Hypersensitive MRI Probes (2018) (0)
Biomimetic scaffold functionalized with magentic nanoparticles to follow in vivo bone regeneration (2020) (0)
New probe for neurodegenerative disease diagnosis (2017) (0)
CMR 2005: 12.03: Phage display screening for peptides targeting the amyloid peptide Aβ1–42 for molecular imaging of the senile plaques in Alzheimer disease (2006) (0)
Synthesis of Isoxazolo(4,5-d)pyrimidinones, and Their Isomerization into Oxazolo(4,5-d)pyrimidinones on Flash Vacuum Pyrolysis. (1995) (0)
CMR 2007: 7.03: Investigation of the structure-stability relationship of macrocyclic and linear MRI contrast agents (2007) (0)
Bifunctional polylactide coated iron oxide nanoparticles for drug delivery and MRI contrast enhancement (2010) (0)
Phospholipase A2 modulation in Alzheimer’s disease: new approach of treatment using peptides able to accede to the brain through the LDL receptor (2016) (0)
Collagen scaffolds labelled with MRI and SPECT contrast agents for non invasive imaging in bone tissue engineering (2017) (0)
Nanohydrogels and Gadolinium Chelates : Seeking for Hypersensitive T1 Probes in MRI (2017) (0)
Title : In vitro study of dendronized nanoparticles designed for targeted multimodal image guided therapy (2021) (0)
New biocompatible nanohydrogels to obtain highly efficient MRI Gd contrast agents (2016) (0)
Synthesis, characterization, and relaxation studies of a fluorinated paramagnetic contrast agent (2017) (0)
Targeting phospholipase A2 for the treatment of Alzheimer's disease through a peptidic modulation (2017) (0)
Comparative study of some C-substituted Gd-DTPA exhibiting non-covalent binding to blood proteins (1998) (0)
Functionalized silica nanoplatform as a bimodal contrast agent for MRI and optical imaging. (2020) (0)
Mémoire ocompatible nanoparticles and gadolinium complexes for MRI plications (2013) (0)
Study of novel galectin-1 targeted peptides in the context of a new and non-invasive papillary thyroid cancer diagnosis and evaluation of their potential inhibitor effect (2016) (0)
Lausanne LANTHANIDE BASED NANOSTRUCTURES FOR BIMODAL T 2-MRI AND OPTICAL IMAGING (2018) (0)
CHAPTER 14 Cellular Magnetic Labeling with Iron Oxide Nanoparticles (2011) (0)
Development of silica nanoparticle s for 1H MRI and Optical Imaging (2020) (0)
Development of a paraCEST and Fluorine MRI Contrast Agent (2020) (0)
Dendrimers like platforms for molecular imaging: characterization of successive generations of paramagnetic dendrimers. Evaluation and perspectives (2016) (0)
Synthesis of a paramagnetic nanoplateform, for the detection of atherosclerotic plaques by magnetic resonance and optical imaging (2017) (0)
Nanohydrogels and Gadolinium Chelates Seeking for Hypersensitive T1 Probes dedicated to lymphatic system imaging (2018) (0)
CMR 2007: 8.02: In vitro characterization of a new Gd complex and its Eu analog, suitable bimodal contrast agents for MRI and optical imaging (2007) (0)
Development of a microfluidic approach for the thermal decomposition synthesis of a nanoparticulate contrast agents (2017) (0)
Erratum to: Charge effect of superparamagnetic iron oxide nanoparticles on their surface functionalization by photo-initiated chemical vapour deposition (2016) (0)
Imaging of papillary thyroid cancer using peptide vectorized iron oxide nanoparticles targeted to galectin-1 (2017) (0)
Bimodal contrast agent for MRI and photoacoustic : synthesis and relaxometric characterization (2018) (0)
Evaluation of Radical Scavenging and Metal Chelating Potential of Cameroonian Propolis and Isolation of Some Chemical Constituents (2022) (0)
EuroNanoMed II NEWS LETTER 1 EuroNanoMed II Who are we ? (2013) (0)
A New Cerebroside Colahetrophylloside A , from ( Sterculiaceae ) and its Antiplamodial activity Ache (2020) (0)
Innovative and Strategic Materials against Cancer: Preclinical Researches on IER5/Cdc25B Targeted Multi-type Wide Spectral Novel Low-molecular-weight Phospha Sugar Antitumor Agents and Tumor Accumulative Higher Sensitive Sugar Dendritic Gd-DTPA Complex MRI Contrast Agents to Innovate in Cancer Thera (2019) (0)
Bimodal (MRI/optical) DTPA Bisamide Complexes and their Self-assembly to Micelles (2012) (0)
Inference of extraction methods on yield and essential oil composition of Ruata graveolens (2020) (0)
A new method of extracting polyphenols from honey using a biosorbent compared to the commercial resin amberlite XAD2. (2021) (0)
Antioxidant Activity and Chemical Constituents from Stem Bark of Ficus abutilifolia. Miq (Moraceae) (2020) (0)
Well-differentiated thyroid cancer diagnostic imaging: development of a non-invasive method by peptidic targeting of galectin-1 (2015) (0)
In vitro α-glucosidase inhibitory activity of isolated compounds and semisynthetic derivative from aerial parts of Erythrina senegalensis DC. (2023) (0)
Contoinuous flow synthesis of nanoparticulate contrast agents : a parametric study (2019) (0)
Synthesis and characterization of fluorinated paramagnetic contrast agents for a future use in the 19F MRI (2017) (0)
Antibacterial and antioxidant activities and phytochemical composition of Stereospermum kunthianum r (0)
C10-Modified Artemisinin Derivatives: Efficient Heme-Alkylating Agents (2005) (0)
SIAN OURNAL OF HEMISTRY (2021) (0)
Nitric oxide attachment to SPIONs: Demonstration of the covalent S NO bond in a nanodelivery system (2020) (0)
A novel pentacyclic triterpene acid from the stem barks of Combretum fragrans F. Hoffm (Combretaceae). (2022) (0)
Euphol from Tapinanthus sp. Induces Apoptosis and Affects Signaling Proteins in Glioblastoma and Prostate Cancer Cells (2022) (0)
NMR chemical shift study of the interaction of selected peptides with liposomal and micellar models of apoptotic cells (2014) (0)
Development of peptide vectorized contrast agents targeting galectin-1 in the context of imaging diagnosis of papillary thyroid cancer (2017) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Sophie Laurent?

Sophie Laurent is affiliated with the following schools:

Sophie Laurent's Academic­Influence.com Rankings

Sophie Laurent's Degrees

Similar Degrees You Can Earn

Why Is Sophie Laurent Influential?

Sophie Laurent's Published Works

Published Works

What Schools Are Affiliated With Sophie Laurent?

Sophie Laurent's AcademicInfluence.com Rankings